Monthly Archives: June 2016

Hetero launches colorectal cancer drug Hyderabad-based pharma major Hetero Drugs has launched its biosimilar ‘Bevacizumab’ in the Indian market under the brand name ‘CizumabTM’. The product is used for the treatment of Metastatic Colorectal Cancer (mCRC). Swiss healthcare giant Roche has filed a lawsuit in the Delhi High Court to prevent the launch of Bevacizumab in India but Hetero Drugs ... Read More »

US authorities recommended against AstraZeneca’s flu vaccine Quadrivalent The Advisory Committee on Immunization Practices (ACIP) of US Centers for Disease Control and Prevention (CDC) has recommended not to use live attenuated influenza vaccine (LAIV), also known as the “nasal spray” flu vaccine during the 2016-2017 flu season. The US authorities have recommended against its use saying that the vaccine showed ... Read More »

More reasons to eat your broccoli Love it or hate it, broccoli is touted as a superfood, offering an array of health benefits. And it’s about to get even more super. University of Illinois researchers have identified candidate genes controlling the accumulation of phenolic compounds in broccoli. Consumption of phenolic compounds, including certain flavonoids, is associated with a lower risk ... Read More »

Roche employees raise funds for vulnerable children in over 90 communities around the world Roche (SIX: RO, ROG; OTCQX: RHHBY) employees in 70 countries and 141 sites come together to participate in the 2016 Roche Children’s Walk, which takes place on the International Day of the African Child. All of the funds raised through the global event will be used ... Read More »

Ajanta Pharma launches drug in US and other top pharma news The National Pharmaceutical Pricing Authority (NPPA) has slapped show-cause notices on 10 top drugmakers, including Sun Pharma, Lupin and Aurobindo Pharma, for not submitting relevant information about the names of formulations manufactured and marketed by them. Besides these companies, notices have also been sent to a few other smaller ... Read More »

FDA accepts to review sNDA for 72 mcg dose of linaclotide in chronic idiopathic constipation Ironwood Pharmaceuticals and Allergan announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for the 72 mcg dose of linaclotide for use in the treatment of adults with chronic idiopathic constipation (CIC). The sNDA for ... Read More »

Make Drinking Water From Sunlight And Humidity Any time have you ever dreamt of life on the open road on that adventurous long distance bicycle tour! Irrespective of age, people with different backgrounds, national and international worlds, all choose the bicycle as their favourite means of travel. The bicycle trek is interesting for many reasons: it’s an exciting challenge that ... Read More »

BASF expands Laromer UV/EB acrylates capacity in Germany LUDWIGSHAFEN, GERMANY: BASF SE expands its existing production facilities for Laromer UV/EB acrylates, which are part of BASF’s C3-Verbund system, at its site in Ludwigshafen, Germany. The additional capacities will be available as of the third quarter of 2016. By significantly increasing its production capacities, BASF is responding to the rising demand ... Read More »